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Exercise is one of the most widely used non‐pharmacological strategies to prevent bone 
resorption during menopause. Given the detrimental consequences of bone demineralization, the 
purpose of this study was to examine the effects of prescribing different exercise volumes on 
bone mineral density and content in previously inactive, post‐menopausal women during a 12‐
month intervention and 1 year after intervention completion. Four hundred post‐menopausal 
women were randomized to either 150 min/wk (MODERATE dose group) or 300 min/wk 
(HIGH dose group) of aerobic exercise. Total bone mineral density (g/cm2) and bone mineral 
content (g) were assessed at baseline, 12 months (end of the intervention) and 24 months 
(follow‐up) using whole body dual‐energy X‐ray absorptiometry. At 12 months, mean bone 
mineral density among women in the HIGH dose group was estimated to be 0.006 g/cm2 (95% 
CI: 0.001‐0.010; P = 0.02) higher than that of women randomized to the MODERATE dose 
group. At 24 months, the mean difference between groups remained statistically significant, 
indicating higher mean bone mineral density among women in the HIGH dose group 
(0.007 g/cm2; 0.001‐0.001; P = 0.04). No significant differences between groups were found at 
any time point for bone mineral content. In an exploratory analysis, women who completed more 
min/wk of impact exercises had significantly higher mean levels of bone mineral density at 
12 months compared to baseline (0.006 g/cm2, 95% CI: 0.006‐0.012; P = 0.03). These findings 
suggest that higher volumes of exercise, especially impact exercise, lead to a smaller decline in 
total bone mineral density, which may remain following intervention completion. 
 






Menopause accelerates bone loss as a result of decreased estrogen production.1 Osteopenia and 
osteoporosis are conditions characterized by low bone mineral density and bone mineral content, 
with a heightened fracture risk.2, 3 Affecting approximately one in three women, post‐
menopausal osteoporosis is a highly prevalent condition and the incidence is expected to increase 
in the upcoming years.4 Osteoporosis‐related fractures are associated with a high risk of 
mortality and morbidity in post‐menopausal women.5 Preventing the long‐term loss of bone in 
post‐menopausal women is therefore a major public health priority given its prevalence and 
impact on physical functionality. 
 
Several lifestyle and pharmacologic interventions to prevent the loss of bone mineral density in 
women have been assessed within randomized settings.6 Pharmacological treatments, such as the 
prescription of bone resorption inhibitors or bone formation stimulators, are widely used in post‐
menopausal osteoporosis to help maintain bone mineral density.7 However, the widespread and 
long‐term use of these drugs is limited because of possible side effects (eg, fever, nausea, muscle 
and bone pain, toxicity, heart disease, and cancer).8 
 
Exercise is one of the most widely used non‐pharmacological strategies to prevent bone 
resorption.9 It is generally acknowledged that regular exercise can positively influence bone 
metabolism.10 Bone is an adaptive tissue, and one of the mechanisms whereby exercise can 
improve bone strength is by increasing muscle mass because of the mechanical load that it exerts 
on the skeleton.11 Studies have shown that the osteogenic effects of exercise are associated with 
activities that induce high muscle tension, such as resistance training,12 and high impact loading 
activities, such as jumping.13 However, findings in post‐menopausal women have been 
inconsistent thus far, with some studies observing improvements in bone mineral density after an 
exercise program,14 while others reported no effects.15, 16 Given the detrimental consequences of 
bone demineralization during menopause, further research is needed to determine the optimal 
dose of exercise that is needed to prevent post‐menopausal bone loss.17 
 
The purpose of the present study was to assess the effects of prescribing different volumes of 
aerobic exercise on total bone mineral density and bone mineral content changes in previously 
inactive post‐menopausal women during a year‐long intervention and 1 year later. We 
hypothesized that women randomized to a higher dose of aerobic exercise would have a slower 
age‐related decline in bone mineral density and content compared to women randomized to a 
lower dose of aerobic exercise. We also hypothesized that women who voluntarily choose to 
spend more time doing impact activities (eg, running, rope skipping, and walking) instead of 
non‐impact activities (eg, cycling, rowing, and swimming) would experience the least amount of 




2.1 Study design and participants 
 
The study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA) are 
described in more details elsewhere.18 This study was a two‐center, two‐arm, 12‐month 
randomized controlled trial conducted in Calgary and Edmonton, Alberta, Canada. A total of 400 
English‐speaking, post‐menopausal women aged 50‐74 years who resided in either Calgary or 
Edmonton were recruited and randomized to either 150 min/wk (MODERATE) or 300 min/wk 
(HIGH) of aerobic exercise. Additional inclusion criteria included the following: being 
recreationally inactive (< 90 min/wk of exercise or if between 90 and 120 min/wk, having a 
VO2max < 34 mL/kg/min as measured by a submaximal fitness test), not currently taking 
hormone replacement therapy, not a current smoker or excessive alcohol drinker (no more than 
two alcoholic drinks/d), a body mass index (BMI) of 22‐40 kg/m2, not previously diagnosed with 
cancer, not currently participating in a weight loss program and having received physician 




Women were randomized to either 150 min/wk (MODERATE) or 300 min/wk (HIGH) of 
aerobic exercise. All women were instructed to exercise 5 d/wk reaching 65%‐75% of heart rate 
reserve during 30 min/session or 60 min/session. Exercise sessions were supervised on at least 
3 d/wk by certified exercise trainers at recreational facilities in Calgary and Edmonton. The 
exercise intervention included a 12‐week ramp‐up period, during which the intensity, volume, 
and frequency of exercise were gradually increased. Women could choose to complete any type 
of aerobic exercise (eg, running, walking, and cycling). The adherence to the intervention was 
monitored by weekly exercise logs that were completed by the participants and verified by the 
trainers. These logs included information on the exercise time spent in the prescribed heart rate 
zones and the rate of perceived exertion (Borg scale, 6‐20). Subsequently, there was no 




2.3.1 Assessment of bone mineral density and bone mineral content 
 
Total bone mineral density (BMD) and bone mineral content (BMC) were measured at baseline, 
12 and 24 months by whole body dual‐energy X‐ray absorptiometry (DXA). Scans were taken 
with a Hologic Discovery A DXA system in Calgary and a General Electric Lunar iDXA in 
Edmonton. The DXA scanner was calibrated every day before use. Staff members were blinded 
to the randomization groups. Scanning instructions and procedures were standardized for all 
women. The analysis of the scans was done using the same protocol in Calgary and in 
Edmonton. 
 
2.3.2 Covariate measures 
 
Baseline characteristics, which include information on medical, menstrual, and reproductive 
history, marital status, education, employment, and history of vitamin, medication, and 
exogenous hormone use, were measured with a Baseline Health Questionnaire (BHQ). 
Osteoporosis medication use was derived from self‐reported (yes/no) information captured with 
the BHQ and was used as a crude indicator of osteoporosis diagnosis. Diet during the past year 
was measured at baseline and at 12 and 24 months with the Canadian Diet History 
Questionnaire19 that was originally developed by the US National Cancer Institute. 
 
2.4 Statistical analysis 
 
For our primary analysis, linear regression models were used to estimate the mean differences in 
total bone mineral density (g/cm2) and bone mineral content (g) between treatment arms at 
12 months (end of the study) and at 24 months (follow‐up) after adjusting for baseline outcome 
values in accordance with an intent‐to‐treat analysis. We re‐examined these results after 
adjusting for baseline covariates that could influence these variables.20 These included the 
following: age (years), years since menopause (years), body fat (%), ethnicity (%), estrogen 
levels (pg/mL), presence of osteoporosis (yes/no), osteoporosis medication use (yes/no), and 
intake of calcium or vitamin D supplementation (yes/no). Assumptions of normality and 
homogeneity were assessed by examining quantile‐quantile plots and histograms of the residuals, 
plots of the residuals vs the fitted values, and plots of the residuals vs the predictor variables. The 
assumption of linearity was examined through the inclusion of polynomial terms into the 
regression analysis. The presence of influential observations was assessed using Cook's distance. 
Sensitivity analyses were conducted to determine whether the results were robust to the removal 
of influential observations if present. In all analyses, we found no gross violations of the 
assumption of normality or homogeneity and all results were robust to the removal of the few 
potentially influential points that were identified using Cook's D (results not shown). Therefore, 
no transformation of the data was needed for these analyses. 
 
We examined potential effect modification for the association between years since menopause, 
percent body fat, osteoporosis medication use (yes/no), vitamin D, or calcium supplementation 
use (yes/no) with bone mineral density and bone mineral content, given their dual effects on 
bone.20 
 
As an exploratory analysis, a per‐protocol analysis was conducted whereby women who did not 
adhere to at least 90% of the exercise prescription were excluded. Including the 12‐week ramp‐
up period, being 90% adherent to the intervention corresponded to completing an average of 
238.5 and 120.7 minutes of physical activity per week over 12 months for those randomized to 
the HIGH and MODERATE dose arms, respectively. 
 
In an additional exploratory analysis, we examined the association between the average amount 
of time spent doing impact exercises and bone mineral density. We classified activities into two 
categories: impact vs non‐impact exercises. We classified impact exercises as those where the 
body touches the ground and generates a gravitational load.21 The following exercises were 
classified as impact exercises: running, walking, hiking, dancing, rope skipping, stair climbing, 
trampoline jumping, snow‐shoeing, as well as playing basketball, badminton, tennis, racquetball, 
or participating in a group fitness class. Examples of exercises classified as being non‐impact 
included cycling, rowing, aquafit classes, swimming, cross‐country skiing, or the use of the 
elliptical or rope machine. We estimated the average amount of time spent doing impact 
exercises every week for each participant. 
 
Analyses were conducted in STATA (version 15.1; StataCorp LLC), and the data were cleaned 




Of the 400 women randomized at baseline, 379 and 330 participants had complete outcome 
assessments at 12 and 24 months, respectively (Figure 1). There were no differences in baseline 
characteristics between treatment arms except for ethnicity, calcium supplementation, and 
multivitamin use. Women in the MODERATE group had a greater percentage of multivitamin 
use, calcium and vitamin D supplementation, and a higher proportion of Caucasian women 
(Table 1). Women were, on average, 58 years of age, mainly Caucasian and overweight with a 
median BMI of 28 kg/m2. Of the 379 women included in this analysis, 25 and 32 women had a 
diagnosis of osteoporosis in the HIGH and MODERATE dose groups, respectively, at baseline. 
No serious harmful events were reported during the intervention.22 
 
 
Figure 1. Participant flow diagram for the BETA Trial (0‐12 mo) and the 12‐mo follow‐up study 
(12‐24 mo), Alberta, Canada, 2010‐2014 
 
In the intention to treat analysis, mean bone mineral density among women randomized to the 
HIGH dose group was estimated to be 0.006 g/cm2 (95% CI: 0.001‐0.010) higher than that of 
women randomized to the MODERATE dose group at 12 months after adjusting for baseline 
outcomes (P = 0.02; Table 2). At 24 months, bone mineral density for the HIGH group was 
estimated to be 0.007 g/cm2 (0.001‐0.013) higher than the MODERATE dose group after 
adjusting for baseline outcomes (P = 0.02; Table 2). No significant differences between groups 
were found for bone mineral content (BMC) at 12 months (P = 0.87) or at 24 months (P = 0.96) 
after adjusting for baseline values (Table 2). 
Table 1. Baseline covariates for the participants randomized to the HIGH‐ and MODERATE‐
dose groups in the Breast Cancer and Exercise Trial in Alberta (BETA), Alberta, Canada, 2010‐
2014 (n = 379) 
Baseline characteristics HIGH‐dose group (n = 192) MODERATE‐dose group (n = 187) 
Age (y) 58.5 [55.7, 62.3] 58 [56, 62.7] 
Weight (kg) 74.8 [67.1, 86.3] 76 [66.4, 87] 
Height (m) 1.63 [1.59, 1.66] 1.61 [1.58, 1.66] 
Body mass index (kg/m2) 28.4 [25.3, 31.8] 28.75 [26, 32.9] 
Age at menopause (y) 50 [47, 52] 50 [48, 52] 
Years post‐menopausal (y) 8.2 [4.7, 14.0] 8.0 [4.5, 13.4] 
Ethnicity 
Caucasian; N (%) 164 (85.4) 173 (92.5) 
Other; N (%) 28 (14.6) 14 (7.5) 
DXA measurements 
Body fat (kg) 29.7 [23.8, 36.8] 29.8 [24.3, 37.7] 
Lean mass (kg) 43.7 [39.8, 47.9] 43.5 [39.5, 47.6] 
Total BMC (g) 2142 [1957, 2411] 2111.00 [1890, 2412] 
Total Bone Area (cm2) 2022 [1898, 2122] 1973.6 [1869, 2114] 
Total BMD (g/cm2) 1.06 [1.01, 1.13] 1.08 [1.00, 1.13] 
Osteoporosis; N (%) 25 (13.0) 32 (17.1) 
Estrogens 
Estrone (pg/mL) 36.9 [30.6, 43.7] 39 [30.9, 47.5] 
Estradiol (pg/mL) 9.3 [7.2, 12.3] 9.7 [7.6, 12.9] 
Calcium supplement; N (%) 82 (42.7) 100 (53.5) 
Vitamin D supplement; N (%) 121 (63.0) 121 (64.7) 
Multivitamin supplement; N (%) 66 (34.4) 82 (43.9) 
Osteoporosis medication; N (%) 15 (7.5) 22 (11) 
Note: Values reported as median [IQR] and N (%) for continuous and categorical variables, respectively. 
Abbreviations: BMC, Bone mineral content; BMD, Bone mineral density; DXA, dual‐energy X‐ray absorptiometry. 
 
We previously reported the changes in body fat mass (kg), lean mass (kg), and VO2max between 
groups following these exercise interventions.22 Briefly, the mean reductions in total fat mass 
were significantly larger in the HIGH compared with the MODERATE dose group (least‐squares 
mean difference, −0.96 kg, 95% CI: −1.71 to −0.22; P = 0.01). Lean mass was also 0.31 kg (95% 
CI: −0.05 to 0.68) higher at 12 months in the HIGH compared to the MODERATE dose group; 
however, this difference was not statistically significant (P = 0.09). Lastly, greater increases in 
VO2max were noted in the HIGH vs MODERATE groups (5.09 vs 3.09 L/kg min; P = 0.05).22 
 
Based on the per‐protocol analysis (n = 211), the magnitude of the estimated effect for bone 
mineral density among women whose adherence to the prescribed exercise intervention was 
≥90% was similar at 12 months compared to what was observed in the intent‐to‐treat analysis, 
and at 24 months, women among the HIGH dose group had higher bone mineral density than 
women in the MODERATE dose group; however, this difference was not statistically significant. 
Furthermore, results remained unchanged for bone mineral content, with no significant 
differences between groups at 12 and 24 months (results not shown). We have previously 
reported adherence data during BETA, finding relatively high exercise adherence with a total 
program adherence of 84.5% in the MODERATE group and 75.2% in the HIGH group.23 
 
Table 2. Mean difference in bone mineral density (g/cm2) and bone mineral content (g) between HIGH‐ and MODERATE‐dose 
groups at 12 mo and at 24 mo after adjusting for baseline values among participants in BETA, Alberta, Canada, 2010‐2014 
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0.007 (0.001 to 0.013) 0.02 

















0.43 (−18.29 to 19.15) 0.96 








Abbreviations: BMC, bone mineral content; BMD, Bone mineral density; CI, Confidence interval; N, number of women completing measures at baseline and 12 
and 24 mo; SD, standard deviation. 
a Mean difference at 12 mo between groups adjusted for baseline. The reference value is the MODERATE‐dose group. 
b P‐value refers to the statistical significance between arms. 
c N refers to the number of women that was adherence to at least 90% of the exercise prescription. 
d Mean minutes per week of exercise completed for women in the study. This average corresponds with a 90% adherence to the exercise prescription. Data are 
adapted from Stone et al.23 
e Mean difference at 24 mo between groups adjusted for baseline. The reference value is the MODERATE‐dose group. 
 
When testing for effect modification, we found that the use of osteoporosis medication 
moderated the association between exercise dose and bone mineral density, indicating that the 
effects of exercise dose on bone mineral density were significantly greater among women 
randomized to the HIGH dose group who were not using osteoporosis medication (0.008 g/cm2, 
95% IC: 0.003‐0.012; P = 0.03). As a result of these findings, we excluded women taking 
osteoporosis medication from the full model (n = 35). Results were not different at the end of the 
intervention (results not shown), but they were no longer statistically significant at the end of 
follow‐up (−0.006 g/cm2, 95% CI: −0.000 to 0.012; P = 0.08) when compared to our intent‐to‐
treat results. No statistically significant interactions were found with elapsed time since 
menopause, body fat (%) or vitamin D and calcium supplementation for bone mineral density 
(Table S1). Regarding bone mineral content, effect modification was not found for any of the 
potential moderators (Table S1). 
 
In an exploratory analysis, we examined the association between bone mineral density and the 
average amount of min/wk that the women spent doing impact exercises. A total of 77 341 
sessions were recorded, of which 839 (1.1%) were missing data on the type of activity performed 
by the women. We observed that individuals who completed an average of >85.4 min/wk of 
impact exercise over the course of a year had significantly higher mean levels of bone mineral 
density at 12 months (0.006 g/cm2, 95% CI: 0.006‐0.012; P = 0.03) compared to women who did 




To our knowledge, this trial is the first to investigate the effects of prescribing different doses of 
exercise on total bone mineral density and bone mineral content in post‐menopausal women 
during a 12‐month intervention and at 24‐month follow‐up. In this 12‐month intervention, 
inactive post‐menopausal women randomized to a HIGH dose group have statistically significant 
higher bone mineral density compared to the MODERATE dose group at 12 months. This 
difference between groups remained 1 year after the end of the intervention. In contrast, we did 
not find significant differences between groups for bone mineral content. Therefore, completing 
a greater volume of exercise may help prevent some of the natural age‐related decreases in bone 
mineral density, and these benefits may remain once the intervention concludes. Lastly, 
completing a higher volume of impact exercises led to a smaller decrease in bone mineral 
density, thus supporting our second hypothesis. 
 
The effects of exercise on bone health in post‐menopausal women have been explored in several 
studies24; however, results remain inconsistent since not all types of exercises have shown 
positive effects on bone mineral density.25, 26 The majority of studies have reported the effects of 
exercise on specific bone regions, such as lumbar spine, femoral neck, or total hip, given the 
clinical relevance of these sites in the prevention of fracture risk.27-30 Other studies, like ours, 
have reported the effects of exercise on whole body bone mineral density.31-34 A comparable 
study is the Physical Activity for Total Health study (PATH)35 Trial, which randomized 173 
post‐menopausal women to a year‐long aerobic exercise intervention or a stretching control 
group. This study reported a non‐significant difference in total bone mineral density between the 
control and the exercise group after the intervention.35 Consistent with our results, some studies 
did not find an increase in total bone mineral density in post‐menopausal women after a 
moderate‐intensity aerobic exercise intervention.26, 36 In our study, we found a decrease in total 
bone mineral density, and one possible explanation could be related to the amount of mechanical 
loading and muscle tension that is needed to increase bone mass.11 The majority of women in 
this study chose to walk,22 which has been shown to be an insufficiently strong stimulus to help 
preserve bone mineral density.15, 24 Impact exercise and resistance training have been shown to 
be very effective modes of exerting a mechanical load37, 38; hence, they may lead to greater 
improvements in bone mineral density. Indeed, our exploratory analysis revealed that greater 
improvements in bone mineral density were seen in women who reported completing a greater 
amount of impact exercises. These results are consistent with previous studies that found benefits 
of impact exercises on bone health.14, 37 
 
We noted that the effects of exercise dose on bone mineral density were significantly greater 
among women who were not using osteoporosis medication. Therefore, women with established 
osteoporosis did not show an added benefit of greater exercise volume on bone mineral density. 
However, these results do suggest that exercise could potentially be used as a non‐
pharmacological strategy to prevent post‐menopausal bone loss and delay the use of osteoporosis 
drugs. However, these results should be interpreted with caution as there were a limited number 
of women taking osteoporosis medication in our intervention. Although non‐significant, our 
results may suggest that elapsed time since menopause may modify the association between 
exercise and bone mineral density, where the effects of exercise dose on bone mineral density 
were greater in women with a longer elapsed time since menopause. Bone mineral density loss 
during menopause is not linear, since it decreases rapidly during the first years of menopause and 
then attenuates.39 It is also possible that women who had lower baseline bone mineral density 
may have less loss due to an inability to lose a large amount of BMD over the course of the 
intervention. Therefore, it is possible that our exercise interventions were unable to prevent some 
of this rapid decrease in bone mineral density seen during and shortly after menopause, which 
corroborates previous findings reported by the PATH Trial.35 
 
Bone mineral content is also an indicator of fracture risk and osteoporosis3; however, most of the 
studies conducted in post‐menopausal women have focused on reporting bone mineral density 
measurements.24 In the present study, we found that both BMD and BMC decreased at 12 and 
24 months for both groups, whereas there were no significant differences between the 
MODERATE and the HIGH group for bone mineral content. Since BMD is a ratio between 
BMC and bone size, variations in BMD could be attributable to variations in both of these 
components. Future studies should report both BMC and BMD measurements to allow for 
further comparisons between these measurements in various populations. 
 
The main limitation of this study was that regional scans for bone mineral density or bone 
mineral content were not performed since bone measurements were not a primary outcome of 
BETA. Therefore, we are unable to assess the effects of these exercise interventions on the total 
hip or the femoral neck, which are of clinical relevance for predicting the risk of fractures. 
Furthermore, DXA alone cannot capture all the benefits that exercise may cause in post‐
menopausal bone health, such that other methods like peripheral quantitative computed 
tomography (pQCT) could be used to better understand the effects of exercise on bone health. 
 
In conclusion, our results suggest that prescribing a higher dose of exercise, especially impact 
exercise, may attenuate some of the natural age‐related declines in total bone mineral density in 
post‐menopausal women and that these benefits may remain once the intervention concludes. 
Despite these findings, it is important to recognize that declines in bone mineral density and bone 




There is currently little evidence on the effects of exercise volume that may be needed to 
improve or prevent age‐related declines in bone mineral density. To our knowledge, this is the 
largest study to investigate the dose‐response effects of exercise on total bone mineral density. 
Our findings suggest that post‐menopausal women could delay some of the loss in total bone 
mineral density by performing a greater volume of aerobic exercise, especially if this exercise 
has a weight‐bearing component. Further studies are needed to corroborate these findings, with 
an emphasis on regional bone mineral density and bone mineral content measurements to 
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